cancer inhibitors trang 11 tải miễn phí từ TAILIEUCHUNG

"cancer inhibitors" trang 11 - tải miễn phí từ Tailieuchung

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol

Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocol

11 20 1

The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: A population-based study

The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: A population-based study

12 21 1

Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR

Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR

8 26 1

Combining genomic analyses with tumourderived slice cultures for the characterization of an EGFR-activating kinase mutation in a case of glioblastoma

Combining genomic analyses with tumourderived slice cultures for the characterization of an EGFR-activating kinase mutation in a case of glioblastoma

9 49 1

Finding the right BCR-ABL1 tyrosine kinase inhibitor: A case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib

Finding the right BCR-ABL1 tyrosine kinase inhibitor: A case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib

5 49 1

PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts

PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts

10 19 1

The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells

The marine triterpene glycoside frondoside A induces p53-independent apoptosis and inhibits autophagy in urothelial carcinoma cells

10 34 1

Validation of an NGS mutation detection panel for melanoma

Validation of an NGS mutation detection panel for melanoma

7 40 1

The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways

The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways

15 39 1

The non-genomic loss of function of tumor suppressors: An essential role in the pathogenesis of chronic myeloid leukemia chronic phase

The non-genomic loss of function of tumor suppressors: An essential role in the pathogenesis of chronic myeloid leukemia chronic phase

8 55 1

Metastatic EML4-ALK fusion detected by circulating DNA genotyping in an EGFRmutated NSCLC patient and successful management by adding ALK inhibitors: A case report

Metastatic EML4-ALK fusion detected by circulating DNA genotyping in an EGFRmutated NSCLC patient and successful management by adding ALK inhibitors: A case report

5 63 1

Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations

Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations

7 38 1

NRASQ61K mutated primary leptomeningeal melanoma in a child: Case presentation and discussion on clinical and diagnostic implications

NRASQ61K mutated primary leptomeningeal melanoma in a child: Case presentation and discussion on clinical and diagnostic implications

6 49 1

In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants

In chronic myeloid leukemia patients on second-line tyrosine kinase inhibitor therapy, deep sequencing of BCR-ABL1 at the time of warning may allow sensitive detection of emerging drug-resistant mutants

6 48 1

An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma

An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma

13 22 1

Response to post-axitinib treatment in patients with metastatic renal cell carcinoma

Response to post-axitinib treatment in patients with metastatic renal cell carcinoma

7 40 1

Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition

Epigenetically maintained SW13+ and SW13- subtypes have different oncogenic potential and convert with HDAC1 inhibition

13 49 1

Relapsing pneumonitis due to two distinct inhibitors of the MAPK/ERK pathway: Report of a case

Relapsing pneumonitis due to two distinct inhibitors of the MAPK/ERK pathway: Report of a case

4 51 1

Off-label use of targeted therapies in osteosarcomas: Data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)

Off-label use of targeted therapies in osteosarcomas: Data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)

9 27 1

Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations

Cost-effectiveness analysis of first and second-generation EGFR tyrosine kinase inhibitors as first line of treatment for patients with NSCLC harboring EGFR mutations

8 42 1

Đầu
1
2
3
4
5
6
7
8
9
10
[ 11 ]
12
13
14
Cuối

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.